PDL BioPharma (PDLI): Q3 EPS of $0.32 beats by $0.02. Revenue of $85.2M (+2.2% Y/Y) in-line. (PR)

|About: PDL BioPharma, Inc. (PDLI)|By:, SA News Editor
PDL BioPharma (PDLI): Q3 EPS of $0.32 beats by $0.02. Revenue of $85.2M (+2.2% Y/Y) in-line. (PR)